Doctor’s Passport

Find your next topic

Explore the current textbook

Available drafts · Clinical review pending
Membership
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
Rapid

Catheter-directed therapy and embolectomy concepts

Essential points for quick revision.

Saved on this device
!
Refractory obstructive PE shock

Persistent shock from confirmed or near-certain pulmonary embolism demands immediate reperfusion planning; anticoagulation alone cannot promptly reverse critical right-ventricular outflow obstruction.

Action: Activate critical care, interventional and cardiothoracic expertise together and decide lytic eligibility explicitly. Use systemic thrombolysis when permitted; after a lytic contraindication such as recent intracranial haemorrhage, select catheter aspiration or mechanical thrombectomy without thrombolytic exposure, or surgical embolectomy. Consider a catheter-delivered thrombolytic only if fibrinolysis is separately judged acceptable.

Synopsis

Select patients who may benefit from catheter-directed or surgical thrombus removal, understand procedural trade-offs, and recognise when anticoagulation or systemic reperfusion remains appropriate.

  • For PE with shock, assess fibrinolysis eligibility explicitly: use systemic thrombolysis when permitted; if lysis is contraindicated, urgent alternatives are catheter aspiration or mechanical thrombectomy without lytic exposure, or surgical embolectomy—not catheter-directed thrombolysis.
  • Do not routinely thrombolyse haemodynamically stable PE, including patients with right-ventricular dysfunction; monitor higher-risk stable patients and prepare rescue escalation.
  • For symptomatic iliofemoral DVT, consider catheter-directed thrombolysis only when symptoms have lasted under 14 days, functional status is good, life expectancy is at least 1 year and bleeding risk is low; do not offer thrombus-removal procedures for femoral, popliteal or calf-vein DVT. All intervention choices require multidisciplinary assessment and local capability.

Key red flags

Cardiac arrest, persistent hypotension, rising lactate or worsening organ perfusion indicates high-risk PE requiring immediate reperfusion assessment.

Recent intracranial haemorrhage, active major bleeding, intracranial neoplasm or recent major surgery may make thrombolytic exposure unacceptable.

Phlegmasia, threatened limb perfusion or severe iliofemoral DVT symptoms despite treatment needs urgent vascular review for selected thrombus-removal strategies.

New neurological change, access-site expansion, haemoglobin fall, pericardial signs or abrupt respiratory deterioration after intervention suggests a major complication.

Limb threat

Massive swelling, cyanosis, severe pain, sensory change or impaired arterial inflow suggests phlegmasia and requires urgent venous and arterial assessment.

Investigation priorities

01
Immediate physiology and bleeding assessmentFirst step

Determine whether urgent reperfusion is needed and which methods remain safe.

Management branches

Emergency PE pathwayReperfusion for haemodynamic collapse

Confirmed or near-certain PE is causing shock, persistent hypotension or cardiac arrest.

  1. Provide expert-led resuscitation, continuous monitoring and anticoagulant assessment while activating critical care, interventional radiology or cardiology, and cardiothoracic surgery without serial referral delay.
  2. Decide fibrinolysis eligibility explicitly. Use systemic thrombolysis when indicated and permissible; if lysis is contraindicated or has failed, choose catheter aspiration or mechanical thrombectomy without thrombolytic exposure, or surgical embolectomy, according to anatomy, time and expertise.
Rescue pathwayDeteriorating initially stable PE

A monitored normotensive patient develops hypotension, worsening hypoperfusion or escalating respiratory failure.

Open full textbook Answer 2 questions
Sources and review status6 sources · checked 13 Sept 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 13 Sept 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom